Hydrochloric Acid → HCID 131734729, compound

HRID 1775125Notes

Reaction equation

HRID 1775125 reaction equation
[ClH:1].O1CCOCC1.[CH3:8][C@H:9]1[C@@H:14]([N:15]([C:17]2[N:25]=[CH:24][N:23]=[C:22]3[C:18]=2[CH:19]=[CH:20][NH:21]3)[CH3:16])[CH2:13][N:12]([C:26]([CH2:28][C:29]#[N:30])=[O:27])[CH2:11][CH2:10]1>C(C(C)=O)C>[CH3:8][C@H:9]1[C@@H:14]([N:15]([C:17]2[N:25]=[CH:24][N:23]=[C:22]3[C:18]=2[CH:19]=[CH:20][NH:21]3)[CH3:16])[CH2:13][N:12]([C:26]([CH2:28][C:29]#[N:30])=[O:27])[CH2:11][CH2:10]1.[ClH:1]

Participants

5

Reactant 3

HCID 313Hydrochloric AcidHCID 312751,4-DioxaneHCID 9926791Tofacitinib

Product 1

HCID 131734729HCID 131734729, compound

Reagents, catalysts & solvents 1

HCID 6569Methyl Ethyl KetoneSolvent

Conditions

Temperature
24 °C

Procedure

A solution of 4M hydrogen chloride in 1,4-dioxane (2.353 mmol) was added to a suspension of tofacitinib free base (0.7 g, 2.24 mmol) in methyl ethyl ketone (10 mL). The resulting white suspension was stirred for 25 hours at 23 to 25° C., filtered, washed with methyl ethyl ketone (2×5 mL) and air-dried for 16 hours to yield 760 mg of tofacitinib hydrochloride as a white solid. 1H NMR analysis showed a molar ratio of tofacitinib hydrochloride to methyl ethyl ketone of approximately 1:0.52 (9.7 wt %). A PXRD taken of this sample is shown in FIG. 10.

Workup

  1. filtrationfiltered
  2. washwashed with methyl ethyl ketone (2×5 mL)
  3. customair-dried for 16 hours

Sources & evidence

ORD record
ord-afb4c54ca83c4d4184dcd31ce281b24c
Source dataset
uspto-grants-2016_02
Patent number
US09260438B2

Reaction notes

Loading…